Skip to main content

US ClosedU.S. Closed

SUPN: Supernus Pharmaceuticals, Inc. Stock Analysis | finqOS

Healthcare · Drug Manufacturers - Specialty & Generic

Supernus Pharmaceuticals, Inc. is a biopharmaceutical firm dedicated to developing and marketing therapies for central nervous system (CNS) disorders within the United States.

52W Range

7thpctl

Volume

0.60×avg

Market Cap

2.54BUSD

P/E Ratio

-22.8TTM

Div Yield

-ann

Loading chart data...

Current StateState loading

Supernus Pharmaceuticals, Inc.

SUPNNASDAQ Global Market·USD·Closed

Supernus Pharmaceuticals, Inc.

SUPNNASDAQ·USD·Closed

$43.73

−1.04%

$43.73

−$0.46 (1.04%)

52W Range

7thpctl

Volume

0.60×avg

Mkt Cap

2.54BUSD

P/E

-22.8TTM

Div Yield

–ann